Hoffman Michael B — SEC Form 4 filings
SEC reporting owner CIK 1290208. 14 Form 4 filings on record with FilingPulse; latest filed 2026-05-29.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-07-03 to 2026-05-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 18 legs across 8 filings — 1,924,154 shares, $4,256,876 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: purchase of 975,610 shares @ $2.05 ($2,000,000) in Annovis Bio, Inc., filed 2025-11-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Annovis Bio, Inc. (ANVS) | Director | 13 | 18 legs · 1,924,154 sh · $4,256,876 | — | 11 |
| Translational Development Acquisition Corp. (TDAC) | Chairman and CEO, Director | 1 | — | — | 1 |
Form 4 filings — Hoffman Michael B
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-29 | 4 | Translational Development Acquisition Corp. (TDAC) | Purchase (P): 53,395 (derivative) @ $0.79 | EDGAR |
| 2026-05-21 | 4 | Annovis Bio, Inc. (ANVS) | Purchase (P): 2,562 @ $1.75 · Purchase (P): 18,849 @ $1.80 · Purchase (P): 54,933 @ $1.90 | EDGAR |
| 2026-04-03 | 4 | Annovis Bio, Inc. (ANVS) | Purchase (P): 713,800 @ $2.10 | EDGAR |
| 2025-12-08 | 4 | Annovis Bio, Inc. (ANVS) | Purchase (P): 30,000 @ $4.34 · Purchase (P): 15,000 @ $4.24 | EDGAR |
| 2025-11-25 | 4/A | Annovis Bio, Inc. (ANVS) | Purchase (P): 1,489 @ $4.13 · Purchase (P): 9,200 @ $3.85 · Purchase (P): 415 @ $4.14 · Purchase (P): 28,096 @ $4.15 | EDGAR |
| 2025-11-25 | 4 | Annovis Bio, Inc. (ANVS) | Purchase (P): 1,489 @ $4.13 · Purchase (P): 9,200 @ $3.85 · Purchase (P): 415 @ $4.14 · Purchase (P): 28,096 @ $4.15 | EDGAR |
| 2025-11-21 | 4 | Annovis Bio, Inc. (ANVS) | Purchase (P): 10,000 @ $3.49 · Purchase (P): 10,000 @ $3.50 | EDGAR |
| 2025-11-18 | 4 | Annovis Bio, Inc. (ANVS) | Purchase (P): 15,000 @ $2.11 | EDGAR |
| 2025-11-12 | 4 | Annovis Bio, Inc. (ANVS) | Purchase (P): 975,610 @ $2.05 | EDGAR |
| 2025-09-03 | 4 | Annovis Bio, Inc. (ANVS) | Grant/award (A): 5,000 @ $2.28 · Grant/award (A): 5,000 @ $2.29 · Grant/award (A): 5,000 @ $2.30 | EDGAR |
| 2025-08-20 | 4 | Annovis Bio, Inc. (ANVS) | Grant/award (A): 6,717 @ $2.60 · Grant/award (A): 5,283 @ $2.59 · Grant/award (A): 5,545 @ $2.58 · Grant/award (A): 1,100 @ $2.57 | EDGAR |
| 2025-06-16 | 4 | Annovis Bio, Inc. (ANVS) | Grant/award (A): 25,000 @ $2.80 · Grant/award (A): 1 @ $2.83 | EDGAR |
| 2025-06-02 | 4 | Annovis Bio, Inc. (ANVS) | Grant/award (A): 5,000 @ $2.43 | EDGAR |
| 2024-07-03 | 4 | Annovis Bio, Inc. (ANVS) | Grant/award (A): 29,600 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1290208 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →